These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


218 related items for PubMed ID: 32771037

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prunella vulgaris L protects glucocorticoids-induced osteogenesis inhibition in bone marrow mesenchymal stem cells through activating the Smad pathway.
    Xi L, Zhang YF, Zhao ZJ, Pan DS, Liang W.
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5691-5696. PubMed ID: 32495904
    [Abstract] [Full Text] [Related]

  • 3. IGF-1 reverses the osteogenic inhibitory effect of dexamethasone on BMP9-induced osteogenic differentiation in mouse embryonic fibroblasts via PI3K/AKT/COX-2 pathway.
    Jiang HT, Ran CC, Liao YP, Zhu JH, Wang H, Deng R, Nie M, He BC, Deng ZL.
    J Steroid Biochem Mol Biol; 2019 Jul; 191():105363. PubMed ID: 31018166
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-200a-3p accelerates the progression of osteoporosis by targeting glutaminase to inhibit osteogenic differentiation of bone marrow mesenchymal stem cells.
    Lv R, Pan X, Song L, Sun Q, Guo C, Zou S, Zhou Q.
    Biomed Pharmacother; 2019 Aug; 116():108960. PubMed ID: 31112871
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acteoside Derived from Cistanche Improves Glucocorticoid-Induced Osteoporosis by Activating PI3K/AKT/mTOR Pathway.
    Li S, Cui Y, Li M, Zhang W, Sun X, Xin Z, Li J.
    J Invest Surg; 2023 Dec; 36(1):2154578. PubMed ID: 36521840
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway.
    Li H, Li T, Fan J, Li T, Fan L, Wang S, Weng X, Han Q, Zhao RC.
    Cell Death Differ; 2015 Dec; 22(12):1935-45. PubMed ID: 26206089
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Zoledronic acid accelerates osteogenesis of bone marrow mesenchymal stem cells by attenuating oxidative stress via the SIRT3/SOD2 pathway and thus alleviates osteoporosis.
    Jin ZH, Wang SF, Liao W.
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):2095-2101. PubMed ID: 32141579
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Morinda officinalis polysaccharide regulates rat bone mesenchymal stem cell osteogenic-adipogenic differentiation in osteoporosis by upregulating miR-21 and activating the PI3K/AKT pathway.
    Wu PY, Chen W, Huang H, Tang W, Liang J.
    Kaohsiung J Med Sci; 2022 Jul; 38(7):675-685. PubMed ID: 35593324
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Silencing of miR-330-5p stimulates osteogenesis in bone marrow mesenchymal stem cells and inhibits bone loss in osteoporosis by activating Bgn-mediated BMP/Smad pathway.
    Jin SL, Bai YM, Zhao BY, Wang QH, Zhang HS.
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4095-4102. PubMed ID: 32374006
    [Abstract] [Full Text] [Related]

  • 20. Dexamethasone induces osteogenesis via regulation of hedgehog signalling molecules in rat mesenchymal stem cells.
    Ma X, Zhang X, Jia Y, Zu S, Han S, Xiao D, Sun H, Wang Y.
    Int Orthop; 2013 Jul; 37(7):1399-404. PubMed ID: 23645083
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.